Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.60    -0.05 (-1.08%)
Bid:
4.60
Ask:
4.70
Spread: 0.10 (2.174%)
Market Cap: £220.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Licensing agreement signed

22 May 2007 11:15

Seeing Machines Limited22 May 2007 22 May 2007 Seeing Machines Limited ("Seeing Machines" or the "Company") SEEING MACHINES LICENSES faceAPI PRODUCT Seeing Machines (AIM: SEE), a leading developer of advanced computer basedimaging software systems, announces today that the Company has signed atechnology licensing agreement with a North American based computer visioncompany. Seeing Machines will provide its unique faceAPI based head trackingtechnology to the client for use within their applications. Seeing Machines willreceive a license fee for each product sold that incorporates the faceAPIproduct. The terms of the licensing agreement are the subject of aconfidentiality agreement and have not been disclosed. Nick Cerneaz, CEO of Seeing Machines, commented: "Signing this agreement isdirectly aligned with our business strategy to generate revenue from licensingour core technology to other product and application developers. This licensingagreement builds on the foundations for our faceAPI business laid over the last2 years of development and we are looking to build this line of our businessfurther in the coming year." Further information about Seeing Machines can be obtained from the companywebsite www.seeingmachines.com. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Peter Ward Erica Nelson+61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480www.seeingmachines.com Notes to editors: About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddevelopers in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLAB(R)provides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. The underlying head pose, eye gazeand facial feature tracking technologies within faceLAB(R) are also packaged inthe faceAPITM product that is available to third party integrators andapplication developers allowing them to incorporate that functionality in theirown developments. Building on these unique face tracking and pupil measurement and monitoringcapabilities, Seeing Machines is also developing the TrueField Analyzer(R), anew ophthalmic device to help clinicians detect and manage glaucoma (and a rangeof other diseases of the human visual system). Seeing Machines' faceLAB(R) product is a computer vision system that is able tomeasure the orientation and position of a human head, as well as detect blinksand estimate gaze-direction. It achieves all of this completely visually througha stereo camera system connected to advanced image processing software, with noattachments required on the subject. The product is designed to allow humanfactors researchers and designers assess the interaction of an operator in anenvironment and this finds application in designing operator environments, suchas cockpits for cars, trucks, trains, and aeroplanes for instance, and otherindustrial design applications, as well as medical and psychological researchsituations. The technology also has application in monitoring automobile driversand if it detects drowsiness or that the driver is distracted and theirattention has been diverted from the road, an alarm can be raised to alert thedriver to either pull over and rest in the case of drowsiness or to pay moreattention to the road. faceLAB(R) works in real-time, enabling the behaviour of a subject to betracked. This technology is paving the way in promoting safer driving conditionsand works to enhance the driving experience and to eliminate accidents causedthrough driver drowsiness or distraction. In addition to the capabilities outlined above the faceAPITMsuite also includesextensive monocular tracking solutions, high precision eye and pupil trackingand monitoring capabilities, advanced automatic initialization and automaticbackground operating modes. The product is a fully featured solution allowingboth automated and manual control modes and providing the host application withextensive information about the user(s) being monitored by the tracking system. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.